Literature DB >> 11991735

In vitro motility analysis of thin filaments from failing and non-failing human heart: troponin from failing human hearts induces slower filament sliding and higher Ca(2+) sensitivity.

Adam Knott1, Ian Purcell, Steven Marston.   

Abstract

Contractility of the myocardium is altered in end-stage heart failure. We investigated whether this was related to functional changes in troponin. We isolated troponin from 1 g samples of end-stage failing, non-failing and foetal human heart and studied its regulation of actin-tropomyosin movement over immobilised HMM by in vitro motility assay. At pCa5.4 the sliding velocity of thin filaments reconstituted with non-failing heart troponin was 52+/-4% more than actin-tropomyosin, with failing heart troponin velocity increased by 35+/-2% and with foetal heart troponin velocity increased by 11+/-4%. Thin filaments containing troponin from failing hearts were more Ca(2+)-sensitive than non-failing heart troponin. EC(50) for the fraction of filaments motile and filament velocity decreased 1.76+/-0.20 and 1.89+/-0.62-fold respectively relative to non-failing heart troponin. With foetal heart troponin the EC(50) decreased 2.16+/-0.23 and 3.50+/-1.73-fold for fraction and velocity respectively. Western blots revealed no difference in troponin T or troponin I isoform expression in troponin from failing and non-failing adult hearts but foetal isoforms of troponin I and T were observed in troponin from foetal heart. The level of PKA phosphorylation of troponin from failing and non-failing heart was not significantly different, however, complete non-specific dephosphorylation of troponin abolished most of the difference between failing and non-failing heart troponin. These findings show functional alterations in troponin in failing hearts which could account for the reduced contractile function but there is no change in troponin isoform expression or PKA phosphorylation. Differential phosphorylation by other kinases may account for altered troponin function. Copyright 2002 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11991735     DOI: 10.1006/jmcc.2002.1528

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  15 in total

Review 1.  Random walks with thin filaments: application of in vitro motility assay to the study of actomyosin regulation.

Authors:  Steven Marston
Journal:  J Muscle Res Cell Motil       Date:  2003       Impact factor: 2.698

Review 2.  Myofibrillar remodeling in cardiac hypertrophy, heart failure and cardiomyopathies.

Authors:  Jarmila Machackova; Judit Barta; Naranjan S Dhalla
Journal:  Can J Cardiol       Date:  2006-09       Impact factor: 5.223

Review 3.  Perspective on the clinical application of troponin in heart failure and states of cardiac injury.

Authors:  Almasa Bass; J Herbert Patterson; Kirkwood F Adams
Journal:  Heart Fail Rev       Date:  2009-04-05       Impact factor: 4.214

4.  Molecular mechanism of the E99K mutation in cardiac actin (ACTC Gene) that causes apical hypertrophy in man and mouse.

Authors:  Weihua Song; Emma Dyer; Daniel J Stuckey; O'Neal Copeland; Man-Ching Leung; Christopher Bayliss; Andrew Messer; Ross Wilkinson; Jordi Lopez Tremoleda; Michael D Schneider; Sian E Harding; Charles S Redwood; Kieran Clarke; Kristen Nowak; Lorenzo Monserrat; Dominic Wells; Steven B Marston
Journal:  J Biol Chem       Date:  2011-05-26       Impact factor: 5.157

5.  Anesthetic Agents Isoflurane and Propofol Decrease Maximal Ca2+-Activated Force and Thus Contractility in the Failing Myocardium.

Authors:  Tao Meng; Xianfeng Ren; Xinzhong Chen; Jingui Yu; Jacopo Agrimi; Nazareno Paolocci; Wei Dong Gao
Journal:  J Pharmacol Exp Ther       Date:  2019-09-12       Impact factor: 4.030

6.  Investigation of changes in skeletal muscle alpha-actin expression in normal and pathological human and mouse hearts.

Authors:  O'Neal Copeland; Kristen J Nowak; Nigel G Laing; Gianina Ravenscroft; Andrew E Messer; Christopher R Bayliss; Steven B Marston
Journal:  J Muscle Res Cell Motil       Date:  2010-08-13       Impact factor: 2.698

Review 7.  Myofilament dysfunction in cardiac disease from mice to men.

Authors:  Nazha Hamdani; Monique de Waard; Andrew E Messer; Nicky M Boontje; Viola Kooij; Sabine van Dijk; Amanda Versteilen; Regis Lamberts; Daphne Merkus; Cris Dos Remedios; Dirk J Duncker; Attila Borbely; Zoltan Papp; Walter Paulus; Ger J M Stienen; Steven B Marston; Jolanda van der Velden
Journal:  J Muscle Res Cell Motil       Date:  2009-01-13       Impact factor: 2.698

8.  In vivo phosphorylation site mapping in mouse cardiac troponin I by high resolution top-down electron capture dissociation mass spectrometry: Ser22/23 are the only sites basally phosphorylated.

Authors:  Serife Ayaz-Guner; Jiang Zhang; Lin Li; Jeffery W Walker; Ying Ge
Journal:  Biochemistry       Date:  2009-09-01       Impact factor: 3.162

9.  Protein kinase C and A sites on troponin I regulate myofilament Ca2+ sensitivity and ATPase activity in the mouse myocardium.

Authors:  YeQing Pi; Dahua Zhang; Kara R Kemnitz; Hao Wang; Jeffery W Walker
Journal:  J Physiol       Date:  2003-08-15       Impact factor: 5.182

10.  Predicting cardiomyopathic phenotypes by altering Ca2+ affinity of cardiac troponin C.

Authors:  Michelle S Parvatiyar; Jose Renato Pinto; Jingsheng Liang; James D Potter
Journal:  J Biol Chem       Date:  2010-06-21       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.